Cardiff Lexington (CDIX) Asset Writedowns and Impairment (2018 - 2024)

Cardiff Lexington (CDIX) reported Asset Writedowns and Impairment of $266000.0 for Q4 2024, up 293.15% on a YoY basis from $67659.2 in Q1 2024, and down 78.58% quarter-over-quarter from $1.2 million in Q2 2024.

Cardiff Lexington (CDIX) Asset Writedowns and Impairment (2018 - 2024) Analysis & Trends

Cardiff Lexington has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $266000.0 in Q4 2024.

  • For the quarter ending Q4 2024, Asset Writedowns and Impairment rose 293.15% year-over-year to $266000.0; the trailing twelve-month figure through Dec 2024 stood at $1.5 million (up 1040.01% YoY), and the FY2024 full-year result was $266000.0, up 101.09% from the prior year.
  • Asset Writedowns and Impairment for Q4 2024 stood at $266000.0, down from $1.2 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $1.2 million in Q2 2024, with the low at -$137719.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn
10 Cardiff Lexington - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 266,000.00
Dec 31, 2024 266,000.00
Jun 30, 2024 1.24 Mn
Jun 30, 2024 1.24 Mn
Dec 31, 2023 -137,719.00
Dec 31, 2023 -137,719.00
Mar 31, 2023 270,000.00
Mar 31, 2023 270,000.00
Dec 31, 2019 -16,338.00
Dec 31, 2019 -16,338.00
Sep 30, 2019 -68,049.00
Sep 30, 2019 -68,049.00
Dec 31, 2018 -2.09 Mn
Dec 31, 2018 -2.09 Mn
Sep 30, 2018 2.09 Mn
Sep 30, 2018 2.09 Mn